Tricuspid Valve Insufficiency clinical trials at UCSF
3 in progress, 1 open to eligible people
Tricuspid valve insufficiency is when the tricuspid valve leaks and allows blood to flow backward in the heart. UCSF is testing a catheter-based valve repair device to study its safety and effectiveness in people with severe symptoms. UCSF is enrolling patients for procedures, follow-up visits, and heart function tests.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
San Francisco, California and other locations
Pivotal Trial to Evaluate the Safety and Effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System
Sorry, not yet accepting patients
Pivotal trial to evaluate the safety and effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System.
San Francisco, California and other locations
TRISCEND II Pivotal Trial
Sorry, in progress, not accepting new patients
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
San Francisco, California and other locations
Our lead scientists for Tricuspid Valve Insufficiency research studies include Sammy Elmariah, MD.
Last updated: